Introduction The optimal guidelines for post-mechanical thrombectomy (MT) blood pressure (BP) management are not well established. While observational studies have shown benefits of lowering BP in ...

Background Blood urea/creatinine (U/Cr) ratio is considered to be an ideal biomarker of dehydration. We investigated the association between the U/Cr ratio trajectory and delayed cerebral ischemia ...

(6) Where ‘D’ is the inner lumen diameter of the catheter, ‘µ’ is the dynamic viscosity of blood, and ‘L’ is the length of the catheter.Some assumptions are required to apply this relationship, ...

Background Antiplatelet and antithrombotic medication management before, during, and after neurointerventional procedures has significant practice variation. This document updates and builds upon the ...

Background A study was undertaken to determine the typical length, diameter and taper of vessels in the anterior cerebral circulation. Methods The sample size was calculated at 100 patients based on ...

Neurovascular catheter technology has rapidly evolved over the past decade. While performance characteristics are well known to the practitioner, the design features of these new-generation catheters ...

Background Patients with intracranial atherosclerotic stenosis (ICAS) are prone to stroke recurrence despite aggressive medical treatment. Further assessment of the anatomy and physiology of ICAS is ...

Background Despite successful recanalization via mechanical thrombectomy (MT), only half of acute ischemic stroke (AIS) patients achieve functional independence. Post-MT hemodynamic features are ...

Objectives This is the first FDA approved IDE study for mechanical thrombectomy to treat distal occlusions. DISTALS is a randomized study planned to evaluate the safety and effectiveness of the ...

Background Transvenous embolization (TVE), such as selective shunt occlusion, is the first line treatment for cavernous sinus dural arteriovenous fistula (CSDAVF). Despite the favorable outcomes of ...

The Society of NeuroInterventional Surgery (SNIS) convened the inaugural Neuro Interventional Oncology (NIO) summit at M D Anderson Cancer Center in Houston, Texas on April 26–27, 2024. Physician, ...

Non-acute subdural hematomas (NASHs) are expected to be the most common cranial neurosurgery pathology encountered by the year 2030. Treatment with surgical evacuation may be necessary, but the rate ...